Test List.xlsx
XLSX spreadsheet 14 KB Posted
- Attached to
- Q301--Pathology Reference lab test services RFQ Amendment 0001 Federal contract opportunity
- Solicitation number
- 36C26022Q0072
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Clarification to questions received.docx | DOCX document | |
| 36C26022Q0072 0001_1.docx | DOCX document | |
| 52.212-2.docx | DOCX document | |
| P09 SOW.docx | DOCX document | |
| S02 36C26022Q0072 0001.docx | DOCX document | |
| S02 36C26022Q0072.docx | DOCX document | |
| 36C26022Q0072_1.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| CPT description | CPTCode | TAT (days) | Estimated Yearly Test Volume | Test Price | Total Cost (test price multiplied by estimated yearly volume) |
| Blood smear review | 85060 | 1 | 28 | ||
| Bone marrow smear interpretation | 85097 | 5 | 19 | ||
| Neisseria gonorrhoeae, amplified probe technique | 87591 | 2 | 22 | ||
| HPV HR | 87624 | 1 | 105 | ||
| HPV HHR genotyping | 87625 | 1 | 6 | ||
| Sputum Cytology | 88108 | 1 | 1 | ||
| Cytopathology, selective cellular enhancement technique with interpretation, except cervical or vaginal | 88112 | 1 | 210 | ||
| Cytopathology, cervical or vaginal, requiring interp by physician | 88141 | 1 | 7 | ||
| Cytopathology, cervical or vaginal, collected in preservative fluid, auto prep, manual screen | 88142 | 2 | 1 | ||
| Cytopathology evaluation of FNA, interpretation and report | 88173 | 1 | 1 | ||
| Cytopathology, cervical or vaginal screened by automated with manual rescreen | 88175 | 1 | 262 | ||
| Flow cytometry cell surface cytoplasmic or nuclear marker technical component only; first marker | 88184 | 1 | 74 | ||
| Flow cytometry cell surface cytoplasmic or nuclear marker technical component only; each additional marker | 88185 | 1 | 1074 | ||
| Flow cytometry interpretation; 16 or more markers | 88189 | 1 | 49 | ||
| Level 1 surgical pathology, gross exam only | 88300 | 1 | 1 | ||
| Level II surgical pathology, gross and microscopic,limited exam | 88302 | 1 | 12 | ||
| Level III surgical pathology, gross and microscopic exam | 88304 | 1 | 179 | ||
| Level IV surgical pathology, gross and microscopic exam | 88305 | 1 | 3045 | ||
| Level V surgical pathology, gross and microscopic exam | 88307 | 2 | 59 | ||
| Level VI surgical pathology, gross and microscopic exam | 88309 | 2 | 3 | ||
| Decalcification procedure | 88311 | 2 | 44 | ||
| Special stain group 1 for microrganisms | 88312 | 1 | 79 | ||
| Special stain group 2 for microrganisms | 88313 | 1 | 49 | ||
| Consultation and report on slides prepared elsewhere | 88321 | 1 | 1 | ||
| Consultation and report of referred material requiring preparation of slides | 88323 | 3+ | 1 | ||
| Immunohistochemistry or immunocytochemistry per specimen; each additional single antibody stain procedure | 88341 | 1 | 258 | ||
| Immunohistochemistry or immunocytochemistry per specimen; initial single antibody stain procedure | 88342 | 1 | 252 | ||
| Immunofluorescence per specimen; initial single antibody stain procedure | 88346 | 1 | 7 | ||
| Immunofluorescence per specimen; each additional single antibody stain procedure | 88350 | 1 | 28 | ||
| Morphometric analysis tumor immunohistochemistry quantitative or semiquantitative per specimeneach single antibody stain procedure; manual | 88360 | 1 | 19 | ||
| In situ hybridization per specimen; each additional single probe stain procedure | 88364 | 1 | 6 | ||
| In situ hybridization per specimen; initial single probe stain procedure | 88365 | 1 | 8 | ||
| Morphometric analysis in situ hybridization manual per specimen; each multiplex probe stain procedure | 88377 | 2 | 44 | ||
| BRAF gene analysis V600 variant(s) | 81210 | 3 | 1 | ||
| EGFR gene analysis, common variants | 81235 | 3 | 1 | ||
| KRAS gene analysis; variants in exon 2 | 81275 | 3 | 1 | ||
| KRAS gene analysis; additional variant(s) | 81276 | 3 | 1 | ||
| NRAS gene variants exon 2 and 3 | 81311 | 3 | 1 | ||
| Cytopathology, non-gyn fluids, washings or brushings, smears with interp | 88104 | 1 | 1 | ||
| Cytopathology, in situ hybridization (eg FISH), urinary tract specimen with morphometric analysis, 3-5 molecular probes, each specimen;manual (Urovysion) | 88120 | 3+ | 1 | ||
| Cytopathology, in situ hybridization, urinary tractspecimen with morphometric analysis, 3-5 molecular probes, each specimen;using computer-assisted technology (Urovysion) | 88121 | 3+ | 1 | ||
| Flow cytometry interpretation; 2-8 markers | 88187 | 1 | 1 | ||
| Flow cytometry interpretation; 9-15 markers | 88188 | 1 | 1 | ||
| Immunohistochemistry each multiplex antibody stain procedure | 88344 | 1 | 1 | ||
| Morphometric analysis in situ hybridization manual per specimen; initial single probe stain procedure | 88368 | 1 | 1 | ||
| Morphometric analysis in situ hybridization using computer-assisted technology per specimen; each multiplex probe stain procedure | 88374 | 2 | 1 | ||
| Crystal identification by light microscopy | 89060 | 1 | 1 | ||
| TOTAL ESTIMATED COST (Grand total of Total Cost column): |
File details come from the government source that posted it. Updated .